Trial intelligence / Profile preview

Tranexamic acid irrigation after mandibular third molar surgery

PACTR202508513258189Phase 3Recruiting

Sponsor
Taofeek Akinniyi
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of tranexamic acid in Impacted lower third molar (2 arms), sponsored by Taofeek Akinniyi. Primary endpoints: Postoperative pain, Postoperative swelling and 1 more. Started Aug 2025; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

Impacted lower third molar

Beyond the preview

Go deeper on PACTR202508513258189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202508513258189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call